These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 23422651)

  • 21. [Development of acute myeloid leukemia from donor cells after allogeneic peripheral blood stem cell transplantation in a female patient with acute monoblastic leukemia].
    Ter Arkh; 2011; 83(3):57-62. PubMed ID: 21675261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative analysis of outcomes of allogeneic peripheral blood stem cell transplantation from related and unrelated donors.
    Kang BW; Moon JH; Chae YS; Kim JG; Jung JS; Cho GJ; Jo DY; Kim YK; Kim HJ; Ryoo HM; Eom HS; Lee SM; Joo YD; Won JH; Park MR; Kim MK; Hyun MS; Sohn SK
    Ann Hematol; 2010 Aug; 89(8):813-20. PubMed ID: 20177897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of postremission consolidation chemotherapy on outcome after reduced-intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia in first complete remission: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Yeshurun M; Labopin M; Blaise D; Cornelissen JJ; Sengeloev H; Vindelov L; Kuball J; Chevallier P; Craddock C; Socie G; Bilger K; Schouten HC; Fegueux N; Goker H; Maertens J; Bunjes D; Arnold R; Nagler A; Mohty M
    Cancer; 2014 Mar; 120(6):855-63. PubMed ID: 24338939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Marrow versus blood-derived stem cell grafts for allogeneic transplantation from unrelated donors in patients with active myeloid leukemia or myelodysplasia.
    Bertz H; Spyridonidis A; Ihorst G; Engelhardt M; Grüllich C; Wäsch R; Marks R; Finke J
    Biol Blood Marrow Transplant; 2012 Jun; 18(6):894-902. PubMed ID: 22108569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allogeneic hematopoietic stem cell transplantation for intermediate cytogenetic risk AML in first CR.
    Imahashi N; Suzuki R; Fukuda T; Kakihana K; Kanamori H; Eto T; Mori T; Kobayashi N; Iwato K; Sakura T; Ikegame K; Kurokawa M; Kondo T; Iida H; Sakamaki H; Tanaka J; Kawa K; Morishima Y; Atsuta Y; Miyamura K
    Bone Marrow Transplant; 2013 Jan; 48(1):56-62. PubMed ID: 22705800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Reduced-intensity stem cell transplantation using allogeneic peripheral blood stem cells from the same donor for relapsed leukemia after bone marrow transplantation].
    Kuroki F; Goto H; Yanagimachi M; Kajiwara R; Fujii H; Isaki S; Takahashi H; Ikuta K; Yokota S
    Rinsho Ketsueki; 2006 Jul; 47(7):639-44. PubMed ID: 16910574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences between graft product and donor side effects following bone marrow or stem cell donation.
    Favre G; Beksaç M; Bacigalupo A; Ruutu T; Nagler A; Gluckman E; Russell N; Apperley J; Szer J; Bradstock K; Buzyn A; Matcham J; Gratwohl A; Schmitz N;
    Bone Marrow Transplant; 2003 Nov; 32(9):873-80. PubMed ID: 14561987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adoptable strategic approaches to improve outcomes of allogeneic peripheral blood stem cell transplantations from unrelated donors.
    Sohn SK; Moon JH
    Transfusion; 2014 Jun; 54(6):1673-80. PubMed ID: 24261633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A.
    Schlenk RF; Döhner K; Mack S; Stoppel M; Király F; Götze K; Hartmann F; Horst HA; Koller E; Petzer A; Grimminger W; Kobbe G; Glasmacher A; Salwender H; Kirchen H; Haase D; Kremers S; Matzdorff A; Benner A; Döhner H
    J Clin Oncol; 2010 Oct; 28(30):4642-8. PubMed ID: 20805454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disease- or therapy-related bone marrow damage cannot be overcome by changes in stem cell source or dose in allogeneic transplantation.
    Novotny JR; Rosenthal C; Elmaagacli AH; Dürig J; Beelen DW; Dührsen U
    Eur J Haematol; 2004 Jul; 73(1):1-9. PubMed ID: 15182331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allogeneic peripheral blood stem cell transplantation using normal patient-related pediatric donors.
    Körbling M; Chan KW; Anderlini P; Seong D; Durett A; Langlinais A; Przepiorka D; Gajewski J; Miller P; Sundberg J; Alilaen P; Bojko P; Mirza N; Claxton D; van Besien K; Khouri I; Andersson B; Mehra R; Champlin R
    Bone Marrow Transplant; 1996 Nov; 18(5):885-90. PubMed ID: 8932841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation.
    Parody R; Martino R; Rovira M; Vazquez L; Vázquez MJ; de la Cámara R; Blazquez C; Fernández-Avilés F; Carreras E; Salavert M; Jarque I; Martín C; Martínez F; López J; Torres A; Sierra J; Sanz GF;
    Biol Blood Marrow Transplant; 2006 Jul; 12(7):734-48. PubMed ID: 16785063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal-antigen-complementary HLA-mismatched siblings.
    Okumura H; Yamaguchi M; Kotani T; Sugimori N; Sugimori C; Ozaki J; Kondo Y; Yamazaki H; Chuhjo T; Takami A; Ueda M; Ohtake S; Nakao S
    Eur J Haematol; 2007 Feb; 78(2):157-60. PubMed ID: 17313562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesenteric inflammatory veno-occlusive disease (MIVOD) after allogeneic peripheral blood stem cell transplantation (PBSCT).
    Pérez-Corral AM; Serrano D; Menarguez-Palanca J; Carrión R; Barreiro I; Gómez-Pineda A; Buño I; Balsalobre P; Diez-Martín JL
    Bone Marrow Transplant; 2008 Feb; 41(3):311-3. PubMed ID: 18026155
    [No Abstract]   [Full Text] [Related]  

  • 36. Allogeneic peripheral blood stem cell transplantation (PBSCT) from HLA-identical sibling donors in children with hematological diseases: a single center pilot study.
    Benito AI; Gonzalez-Vicent M; Garcia F; Balas A; Quintero V; Madero L; Vicario JL; Diaz MA
    Bone Marrow Transplant; 2001 Sep; 28(6):537-43. PubMed ID: 11607765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved outcome in relapsed and refractory myeloid malignancies for unrelated vs related donor allogeneic peripheral blood-derived hematopoietic cell transplantation.
    Denz U; Bertz H; Ihorst G; Wäsch R; Finke J
    Bone Marrow Transplant; 2010 Aug; 45(8):1309-15. PubMed ID: 20062094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [CD34+ cell dose and hematologic recovery in allogeneic peripheral blood stem cell transplantation].
    Sawada H; Wake A; Yamasaki Y; Izumi Y
    Rinsho Ketsueki; 2000 Jun; 41(6):500-6. PubMed ID: 10921350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regression of a renal cell carcinoma following allogeneic peripheral blood stem cell transplant for acute myeloid leukaemia: evidence of a graft-versus-tumour effect without significant graft-versus-host disease.
    Scott M; Lawrance J; Dennis M
    Br J Haematol; 2012 Oct; 159(1):1. PubMed ID: 22845006
    [No Abstract]   [Full Text] [Related]  

  • 40. Disseminated Scopulariopsis brevicaulis infection in an allogeneic stem cell recipient.
    Vignon M; Michonneau D; Baixench MT; Al-Nawakil C; Bouscary D; Buzyn A; Salmon D; Paugam A
    Bone Marrow Transplant; 2011 Sep; 46(9):1276-7. PubMed ID: 21113187
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.